Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer

10 Nov 2023

Abstract excerpt

BACKGROUND: Accumulating evidence supports the significant role of human microbiome in development and therapeutic response of tumors. Circulating microbial DNA is non-invasive and could show a general view of the microbiome of host, making it a promising biomarker for cancers. However, whether circulating microbiome is associated with prognosis of non-small cell lung cancer (NSCLC) and its potential mechanisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Ferroptosis and cancer prognosis
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37950236
DOI: 10.1186/s12967-023-04582-w

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerPMID 37950236Read ↗

Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancerSemantic proximity Read ↗

Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancerSemantic proximity Read ↗

Microbial biomarker development for detection and prognosis of early-stage non-small cell lung cancerSemantic proximity Read ↗

Comprehensive analysis of microbiota signature across 32 cancer typesSemantic proximity Read ↗

Gut Metatranscriptomics Based De Novo Assembly Reveals Microbial Signatures Predicting Immunotherapy outcomes in Non-Small Cell Lung CancerSemantic proximity Read ↗

The characteristics of intratumoral microbial community reflect the development of lung adenocarcinomaSemantic proximity Read ↗

Distinct Functional Metagenomic Markers Predict the Responsiveness to Anti-PD-1 Therapy in Chinese Non-Small Cell Lung Cancer PatientsSemantic proximity Read ↗

Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma.Semantic proximity Read ↗

Specific gut microbiome signature predicts the early-stage lung cancerSemantic proximity Read ↗

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces TogetherSemantic proximity Read ↗

Microbial Biomarkers for Lung Cancer: Current Understandings and LimitationsSemantic proximity Read ↗

Unveiling the distinctive variations in multi-omics triggered by TP53 mutation in lung cancer subtypes: An insight from interaction among intratumoral microbiota, tumor microenvironment, and pathology.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.